President at Jacinto Convit World Organization, Inc (JCWO) - California City, California, United States
The Jacinto Convit World Organization (JCWO) is a U.S. nonprofit and non-governmental organization incorporated in 2014, that contributes primarily to important areas of public health, such as cancer and infectious diseases in developing countries. JCWO focuses on cancer research and diagnostics through two main programs: Cancer Immunotherapy (CI) and Molecular Diagnostics (MD).The CI program currently develops a personalized breast cancer therapeutic vaccine, named ConvitVax, designed by Dr. Jacinto Convit during his last years of life. Previous preclinical studies and a small human experience, showed this therapy to be potentially safe and effective, as well as possibly establishing immune system memory. ConvitVax is targeted to underprivileged patients who have very little or no access to new cancer treatments and in some cases to standard of care treatments.The MD program supports the development and expansion of a personalized, precise and free of cost diagnostic service for various types of cancers and infectious diseases to benefit underprivileged and underserved patients in developing countries who do not have access to these specialized tests. JCWO's philosophy is based on Dr. Convit's ideals and humanistic approach to develop treatments that are accessible for the underprivileged population, especially in poorer countries. Dr. Convit, although a man of science, had a profound humanist approach tied to his work. He dedicated himself to curing the most feared diseases such as leprosy, leishmaniasis, among other tropical endemic diseases, and cancer; never leaving behind the important meaning of truly caring about the patient as a human being. He devoted himself to train new generations of professionals and build multidisciplinary teams, as he was a strong believer in the beneficial impact of educating the new generations, and the success of team efforts over individual work.